Cerebellar ataxia with glutamic acid decarboxylase autoantibodies

Neurology. 1999 Mar 10;52(4):857-9. doi: 10.1212/wnl.52.4.857.

Abstract

Degenerative cerebellar ataxia with autoantibodies against glutamic acid decarboxylase (GAD) is a rare disorder and may represent a subset of ataxias previously classified as idiopathic. The authors report a patient with progressive cerebellar ataxia, insulin-dependent diabetes mellitus, and GAD antibodies who responded to i.v. immunoglobulins.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Autoantibodies / immunology*
  • Cerebellar Ataxia / enzymology*
  • Cerebellar Ataxia / immunology*
  • Cerebellar Ataxia / therapy
  • Female
  • Glutamate Decarboxylase / immunology*
  • Glutamate Decarboxylase / metabolism*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use

Substances

  • Autoantibodies
  • Immunoglobulins, Intravenous
  • Glutamate Decarboxylase